UY26319A1 -
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE PHARMACEUTICAL TRAMADOL, IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A # 100 MG / ML WATER-SOLUBILITY AND PROCEDURE
- Google Patents
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE PHARMACEUTICAL TRAMADOL, IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A # 100 MG / ML WATER-SOLUBILITY AND PROCEDURE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal ChemiefiledCriticalGruenenthal Chemie
Priority to UY26319ApriorityCriticalpatent/UY26319A1/en
Publication of UY26319A1publicationCriticalpatent/UY26319A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La invención se refiere a formas farmacéuticas de administración oral al menos parcialmente retardadas cuya sustancia activa farmacéutica tramadol se encuentra al menos parcialmente en forma de compuesto formado in situ con una hidrosolubilidad 100 mg/ml, y procedimientos para su preparación.The invention relates to at least partially delayed oral dosage forms whose pharmaceutical active ingredient tramadol is at least partially in the form of a compound formed in situ with a water solubility of 100 mg / ml, and methods for their preparation.
UY26319A2000-08-312000-08-31
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE PHARMACEUTICAL TRAMADOL, IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A # 100 MG / ML WATER-SOLUBILITY AND PROCEDURE
UY26319A1
(en)
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE PHARMACEUTICAL TRAMADOL, IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A # 100 MG / ML WATER-SOLUBILITY AND PROCEDURE
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE PHARMACEUTICAL TRAMADOL, IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A # 100 MG / ML WATER-SOLUBILITY AND PROCEDURE
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE PHARMACEUTICAL TRAMADOL, IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A # 100 MG / ML WATER-SOLUBILITY AND PROCEDURE
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN FORM OF A DEPOSIT FORMED IN SITU WITH A HYDROSOLUBILITY <O = 100 MG / ML, AND PROCEDURE FOR PREPARATION
SOLID PREPARATION FOR QUICK DISINTEGRATION, USE OF A LITTLE HYDROXYPROPILCELULOSE IN SUCH PREPARATION AND METHOD TO IMPROVE THE ORAL DISINTEGRABILITY OF THE SAME
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE PHARMACEUTICAL TRAMADOL, IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A # 100 MG / ML WATER-SOLUBILITY AND PROCEDURE
PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE PHARMACEUTICAL SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A HYDRO-SOLUBILITY <100 MG / ML, AND PROCEDURE FOR